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 Voluntariness of Consent to Research:
 A Preliminary Empirical Investigation
 by Paul S. Appelbaum, Charles W. Lidz, and Robert Klitzman
 Providing informed consent to
 participate in research?a pri
 mary pillar of the ethical con
 duct of research?is based on three
 components: adequate information,
 a competent decision-maker, and a
 voluntary decision process.1
 Techniques have been developed to
 assess the content and adequacy of
 information disclosures during the
 informed consent process2 and the
 decisional capacity of people recruit
 ed to participate in research.3 But
 voluntariness of consent has been
 more resistant to investigation, leav
 ing policy-makers with little guid
 ance for their efforts to insure that
 prospective research subjects are able
 to exercise meaningful choice about
 whether to participate in research.
 Notwithstanding the paucity of
 empirical data, a considerable
 amount of regulation aimed at pro
 moting voluntary choice has been
 promulgated in response to concerns
 over possible coercive influences in
 recruitment for research studies.4 In
 addition, many IRBs have developed
 internal policies, e.g., limiting the
 incentives that can be provided to
 research subjects5 or precluding
 recruitment of patients without their
 physician's approval. Given that
 additional protections can impede
 recruitment and/or raise its costs?
 and that the populations affected by
 these protections are often among
 those for whom the knowledge base
 is smallest and the concomitant need
 for research particularly great?it is
 Paul S. Appelbaum, Charles W. Lidz, and Robert
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 important to know to what extent
 current approaches are successful in
 mitigating the problem.
 Existing data, however, are of
 limited utility for that purpose.
 Studies focus largely on two popula
 tions: subjects who receive financial
 incentives and research participants
 in studies in the developing world.
 Minimal information is available
 regarding other categories of sub
 jects.6
 Offering financial incentives to
 participate in research has raised
 concerns that compensation might
 unduly influence people's decisions
 about whether to enroll in research,
 leading them to disregard the poten
 tial risks of participation.7 Studies of
 decision-making using hypothetical
 research protocols suggest that
 incentives can influence decisions,
 but that they generally do not lead
 people to ignore research risks.8 The
 only in vivo studies of which we are
 aware examined the impact of vary
 ing levels of payment on substance
 abusers' attendance at follow-up ses
 sions; higher levels of payment were
 associated with better attendance,
 without greater perceived coercion
 or drug use.9
 Populations in developing coun
 tries are often thought to be subject
 to a variety of coercive influences,
 ranging from pressures exerted by
 authority figures to difficulty under
 standing that research participation
 is voluntary.10 For instance, in stud
 ies conducted in Africa and Asia,
 many people said they did not per
 ceive that they were free to make
 decisions about research participa
 tion or to withdraw from a study in
 which they were enrolled.11
 However, studies that asked directly
 about the sources of such pressure
 revealed that people infrequently
 attributed these influences to the
 researchers' themselves,12 leaving
 open the question of how such
 effects could be mitigated.
 Interpretation of the studies con
 ducted in developing countries about
 issues related to financial incentives
 is complicated by the variety of
 assessment approaches that have
 been used, making it difficult to
 compare data across studies. The
 studies were often based on a single
 question and nearly all focused on a
 single subject population, usually
 with a constricted range of inde
 pendent variables. These limitations
 hamper efforts to identify predictors
 of diminished voluntariness as well
 as motives for participating in
 research.
 Given the absence of accepted
 measures of voluntariness in research
 settings and the limited amount of
 available data, our study was
 designed to develop a more compre
 hensive approach to assessing volun
 tariness of consent to research and
 to generate preliminary data on the
 extent and correlates of limitations
 on voluntariness across diverse areas
 of research.
 Study Methods
 The individuals recruited for this study had previously agreed to
 I November-December 2009 IRB: Ethics & Human Research
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 participate in a clinical trial (referred
 to in this report as their "primary
 study") at a major university med
 ical center in one of five areas of
 research: substance abuse, cancer,
 HIV, interventional cardiology, or
 depression. After giving informed
 consent for their primary study, they
 were asked by research staff for that
 study if they would be willing to be
 contacted about participating in this
 additional study of voluntariness.
 Those who responded affirmatively
 were contacted in person or by tele
 phone, given information about the
 study, and offered $20 for their par
 ticipation. Distribution of partici
 pants in our study by category of
 research is shown in Table 1.
 Because of the method of recruit
 ment, we cannot know the number
 of potential participants who were
 not asked about being contacted, or
 who declined to be approached.
 Instrument development began
 with an initial conceptualization of
 potential limitations on voluntari
 ness, based on a model of voluntary
 decision-making rooted in the law of
 informed consent.13 The premise
 underlying the law's approach to
 voluntariness is that although all
 decisions are susceptible to multiple
 influences, voluntary decisions
 should reflect the will of the deci
 sion-maker rather than of another
 person. This is shown in the legal
 rule that consent is ineffective if
 given under duress. Influences that
 may render decisions involuntary
 share a common set of characteris
 tics: they are external, intentional,
 illegitimate, and causally linked to
 the choice of the person participat
 ing in research.14 Drawing on the
 work of sociologist Talcott Parsons,
 who conceptualized the mechanisms
 by which one person can exert influ
 ence on the decisions of another,15
 we identified offers, pressures, or
 threats related to research participa
 tion as those types of influence most
 likely to meet these criteria.
 Interviews were then conducted with
 15 research staff members who rou
 tinely obtain consent from individu
 als willing to enroll in research
 about the offers, pressures, and
 threats that they observed in the
 research setting to discover their
 views on individuals' motivations for
 agreeing to provide consent. We also
 conducted interviews with 19 recent
 ly recruited research subjects from a
 variety of research projects who
 were asked a parallel set of ques
 tions. The interviews were digitally
 recorded, transcribed, and summa
 rized to highlight key aspects of par
 ticipants' responses.
 Based on the information
 obtained in these interviews?which
 suggested that a broad understand
 We identified offers, pressures,
 or threats related to research
 participation as the types of
 influence most likely to reflect
 mechanisms by which one person
 can exert influence on the
 decisions of another.
 ing of motivations is required to
 assess the extent to which research
 subjects' voluntariness may be limit
 ed?we developed a questionnaire
 that addressed three areas: demo
 graphic data, motivations for partici
 pating in research, and experience of
 offers, pressures, or threats. The
 questionnaire asked respondents to
 choose from among 14 possible
 motivations for enrolling in research
 (see Table 2). If they identified a
 motivation as having played some
 role in their decisions, they were to
 indicate on a scale of one to 10 the
 degree of influence associated with
 that motivation. They were then
 asked separately whether they had
 been subject to offers, pressures, and
 threats, and if so, to describe 1)
 what happened, 2) the extent to
 which it influenced their decisions,
 and 3) the degree to which they con
 sidered the offer, pressure, or threat
 to have been unfair (again on scales
 of one to 10). We also asked respon
 dents about the risks they perceived
 were associated with the primary
 study and the role of offers, pres
 sures, or threats in making the risks
 worth accepting. Finally, respon
 dents completed a modified version
 of the MacArthur Perceived
 Coercion Scale16 and a modification
 of the Coercion Ladder17 that we
 refer to as the Voluntariness Ladder.
 These instruments are previously
 published measures of voluntariness
 of decisions in treatment contexts.
 This study was approved by the
 institutional review board (IRB) of
 the New York State Psychiatric
 Institute, and participants gave writ
 ten informed consent. We inter
 viewed 88 participants a median of
 three weeks after they consented to
 participate in their primary study (in
 all cases a clinical trial) (mean: 4.6
 +/- 4.8 weeks). Interviews were con
 ducted by a trained research assis
 tant, were digitally recorded for pur
 poses of analysis, and took approxi
 mately one-half hour to complete.
 Study Findings
 Table 3 provides descriptive char acteristics of the 88 respondents.
 Of particular note, roughly one-third
 had participated in clinical research
 prior to being recruited for their pri
 mary study; this figure is substantial
 ly greater than the approximately
 10% of adults in the United States
 who report having participated in a
 clinical research study18 but could be
 expected to be elevated among a
 group of current research partici
 pants.
 The number of respondents
 endorsing each of 14 possible moti
 vations for research participation,
 and the extent to which their ratings
 of importance (on a one to 10 scale)
 tended to cluster in the upper or
 lower range of the scale are shown
 in Table 2. The possibility of better
 care, trust in the people doing the
 research, and the reputation of the
 host institutions were frequently
 cited as important motivations
 IRB: Ethics & Human Research November-December 2009 .-1-,
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 across all categories of respondents.
 However, some differences could be
 identified across the various respon
 dent groups. Comparing the impor
 tance of the motivation variables
 among respondents who were partic
 ipating in oncology, substance abuse,
 and other clinical trials, significant
 differences exist for the availability
 of free treatment (ANOVA, df = 83,
 F = 14.41, p < 0.0001; substance
 abuse highest and oncology lowest);
 how seriously respondents needed
 help for their condition (ANOVA, df
 = 84, F = 5.07, p < 0.01; substance
 abuse highest and oncology lowest);
 advice from their doctors or nurses
 (ANOVA, df = 86, F = 19.56, p <
 0.0001; oncology highest and sub
 stance abuse lowest); and desire to
 help others with the same medical
 condition (ANOVA, df = 85, F =
 5.22, p = .0073; oncology highest
 and substance abuse lowest).
 Respondents who were enrolled in
 substance abuse trials placed less
 emphasis on altruism as a motiva
 tion for participation and more on
 the availability of free treatment and
 the seriousness of their need for
 treatment. On the other hand,
 respondents in oncology trials?who
 are faced with life-threatening illness
 es?placed the greatest weight of the
 three respondent groups on advice
 from their medical caregivers. No
 one pattern of motivation to enroll
 in a trial appeared to be characteris
 tic of all the areas of clinical research
 examined in this study.
 A factor analysis of possible moti
 vations that were endorsed by more
 than a small number of respondents
 was performed, using a principal
 components analysis and a varimax
 rotation that yielded two factors, as
 demonstrated in Table 4. The first
 factor, which we label "Help and
 Trust," drew most heavily on the
 possibility of getting better care,
 access to treatment not otherwise
 available, how seriously help was
 needed, trust in the people doing the
 research study, and the reputation of
 the institution. The second factor,
 which we call "Free Treatment," was
 based primarily on the availability of
 free treatment, not getting advice
 from a doctor or nurse, and not hav
 ing altruistic motivations. Although
 there were no significant differences
 in the distribution of the first factor
 among the three types of research
 (ANOVA, df = 60, F = 0.25, p =
 0.78), the second factor did differ
 significantly, being strongest for
 respondents who participated in the
 substance abuse studies and weakest
 for those in the oncology trials
 (ANOVA, df = 60, F = 18.73, P <
 0.0001).
 Constraints on Voluntariness.
 Offers tied to research participation
 were reported by 31 respondents
 (35%), pressures by three (3%), and
 threats by none. Most respondents
 who reported offers rated them as
 having had little importance in their
 decision-making (26 of 31 respon
 dents assigned an importance rating
 in the lower half of the one to 10
 scale, with 19 of those giving it the
 lowest possible score). Only one
 respondent assigned the offer an
 importance of 10 out of 10. Of the
 three respondents who reported pres
 sures, none rated the importance of
 the pressure in the upper half of the
 scale.
 Respondents also completed two
 global measures of voluntariness: the
 Perceived Coercion Scale and the
 Voluntariness Ladder. Scores on the
 Perceived Coercion Scale ranged
 from zero to five, based on true/false
 responses to five questions, with
 higher numbers indicating increased
 perceptions of coercion. Scores were
 available for 86 respondents; of
 those, 65 respondents had a score of
 zero, 18 had a score of one, and
 three had a score of two. Most of
 the positive indicators of coercion
 (18 of 25) came from a single ques
 tion (True/False: "It was my idea to
 sign up for the research project"),
 which may have been interpreted
 merely as inquiring about the source
 of a suggestion about participation,
 and thus may not be an accurate
 indicator of constrained volition.
 Thus, there was very little evidence
 from the Perceived Coercion Scale
 that respondents perceived their deci
 sions as having been coerced in any
 way. Confirmatory evidence comes
 from the data generated by the
 Voluntariness Ladder, a simple meas
 ure that asks subjects to rate how
 voluntary their decision was on a
 one to 10 "Ladder," with one indi
 cating a choice that is not at all vol
 untary and 10 a completely volun
 tary choice. Of the 85 respondents
 for whom data were available, 73
 rated their decisions as completely
 voluntary and only one assigned a
 rating in the lower half of the scale
 (i.e., a score of five out of 10). Scores
 for the Perceived Coercion Scale and
 the Voluntariness Ladder were mod
 erately but significantly correlated (r
 = 0.38, p = 0.0003), though neither
 score was predicted by any of the
 descriptive variables.
 Relationships between the
 Perceived Coercion Scale and
 Voluntariness Ladder scores, respec
 tively, and motivations for participa
 tion were significant in a small num
 ber of cases. Higher scores on the
 Perceived Coercion Scale (i.e., greater
 perceived coercion) were associated
 with greater importance of helping
 others as a motivation for research
 participation (ANOVA, df = 85, F =
 4.6, p = 0.03), and increased impor
 tance of an offer in the decision
 (ANOVA, df= 85, F = 5.27, p =
 0.02). They were also associated
 with higher ratings of the impor
 tance of "advice from your doctor or
 nurse" (ANOVA, df = 84, F = 5.33,
 p = 0.02), but this association may
 be due to the previously noted ambi
 guity in the scale's question regard
 ing the source of the idea for
 research participation. None of these
 variables, however, was significantly
 associated with scores on the
 Voluntariness Ladder.
 Discussion
 This study's approach to assessing voluntariness involved a set of
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 questions aimed at directly ascertain
 ing respondents' views regarding the
 presence and importance of offers,
 pressures, and threats?along with
 two global measures of perceived
 coercion/voluntariness?to their deci
 sions about research participation.
 To obtain a more complete picture
 of decision-making, we also took
 into account the positive motivations
 for enrolling in research and the
 importance of these considerations.
 Taken as a whole our data sug
 gest that individuals have diverse
 reasons for wanting to participate in
 research, and that?consistent with
 the existing literature on research
 subjects' motivations19?their deci
 sions are usually driven by more
 than one consideration. For exam
 ple, respondents indicated that the
 need for help with a significant med
 ical condition or the desire for a
 higher level of care was frequently
 combined with a high degree of trust
 in the investigator and institution as
 factors that contributed to their deci
 sion to participate in research; this
 association existed regardless of the
 medical condition for which they
 sought an intervention by enrolling
 in a clinical trial. However, there was
 systematic variation in other motiva
 tions by the nature of the condition
 and the intervention being studied.
 For instance, for respondents who
 participated in substance abuse tri
 als, decisions seem to have been driv
 en most strongly by the availability
 of free care?not usually conceived
 of as an incentive, but perhaps rea
 sonably understood in this way.
 Notably, in this sample of clinical
 trials from diverse areas of medicine
 there was little evidence of con
 straints on voluntariness, and when
 such influences were present they
 almost never were reported as hav
 ing played a significant role in indi
 viduals' decisions. Specifically,
 although offers were common, they
 rarely were perceived as playing a
 major role in the decision-making
 process. Even if they had, we would
 still need to inquire whether they led
 individuals to undervalue or ignore
 significant research-related risks
 before we concluded there was rea
 son for concern. These findings are
 consistent with a growing body of
 literature from both empirical and
 theoretical perspectives suggesting
 that the potential for incentives to
 act as constraints on voluntariness
 has been overrated.2-0 Only three
 respondents reported pressures
 placed on them by other people to
 enroll in a research study or to forgo
 participation, and none of the pres
 sures reached a level of importance
 that appeared to have materially
 influenced their decisions. No
 respondents reported receiving overt
 threats.
 Uur findings reveal little
 evidence of constraints on
 voluntariness, and when such
 influences were present they did
 not play a significant role in
 individuals' decision-making
 process.
 Although these data are reassur
 ing with regard to the degree of vol
 untariness of decisions to enter clini
 cal trials, they provide some hints of
 areas that might warrant further
 exploration regarding their influence
 on voluntary decision-making.
 Offers to prospective research sub
 jects?usually direct financial com
 pensation?have been a focus of
 concern for IRBs and research regu
 lators for many years, and the data
 here concerning their impact on vol
 untariness were somewhat equivocal.
 Although the presence of an offer
 was associated with significantly
 lower scores on the Perceived
 Coercion Scale (i.e., less perceived
 coercion), scores rose as the impor
 tance of the offer to the individual's
 decision-making increased.
 Paradoxically, higher scores on the
 Perceived Coercion Scale were also
 associated with the greater impor
 tance of helping others?i.e., altru
 ism?in individuals' decision-mak
 ing. One explanation for this is that
 individuals who feel "compelled" to
 help others, for moral or personal
 reasons, perceive themselves as less
 free to turn down the opportunity to
 participate in a clinical trial.
 Whether that phenomenon, if con
 firmed, should be of concern to poli
 cy-makers and ethicists is unclear,
 since altruism is generally regarded
 as the least problematic motivation
 for participation in research. Finally,
 when advice from physicians or
 nurses played a more important role
 in decision-making, respondents
 tended to have higher scores on the
 Perceived Coercion Scale, suggesting
 that this source of advice may leave
 individuals feeling less free to say no;
 however, since the relevant question
 on the scale is susceptible to differing
 interpretations, this finding is in need
 of confirmation using alternative
 approaches.
 These data, of course, have limita
 tions that should be underscored.
 They are derived from a newly
 developed (though we would argue
 face-valid) conceptualization of vol
 untariness and its constraints21 and a
 previously untested approach to
 assessment. Moreover, they reflect
 the experiences of a relatively small
 number of individuals who partici
 pated in a limited group of clinical
 trials at a single academic medical
 center. An additional limitation
 inherent in the approach taken here
 is that our assessment of constraints
 on voluntariness was based on the
 reports of research subjects them
 selves, both with regard to their spe
 cific experiences and the degree to
 which their decisions were con
 strained. Insofar as they may have
 failed to recognize or report the pres
 ence or impact of a problematic
 influence on their decisions, we
 would not have been able to detect it
 here. However, this is a limitation
 with which the field of research
 ethics may need to live for now,
 because?outside of an experimental
 setting?it does not appear feasible
 to assess influences on individuals'
 IRB: Ethics & Human Research November-December 2009 |?I-, _ 13
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 decision-making other than from the
 perspective of the individuals them
 selves.
 Thus, although these data in
 themselves offer no reasons for con
 cern about constraints on voluntari
 ness regarding decisions about
 research participation, we caution
 against relying on the data for pur
 poses other than the design of fur
 ther research in this area. Such future
 research might usefully aim at vali
 dating assumptions prevailing in
 existing regulations and policies
 regarding groups at heightened risk
 of impaired voluntariness; identifying
 approaches to recruitment that can
 impair voluntariness (e.g., substantial
 incentives); and developing methods
 of reducing the possibility that indi
 viduals may not be able to make an
 adequately voluntary decision about
 research participation.
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